Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exponent (EXPO) Gains from Investment Securities: 2010-2025

Historic Gains from Investment Securities for Exponent (EXPO) over the last 4 years, with Apr 2025 value amounting to $4.2 million.

  • Exponent's Gains from Investment Securities fell 38.70% to $4.2 million in Q2 2025 from the same period last year, while for Apr 2025 it was $12.6 million, marking a year-over-year decrease of 57.57%. This contributed to the annual value of $379,029 for FY2025, which is 18.18% down from last year.
  • Exponent's Gains from Investment Securities amounted to $4.2 million in Q2 2025, which was up 163.67% from $1.6 million recorded in Q1 2025.
  • Exponent's 5-year Gains from Investment Securities high stood at $15.6 million for Q2 2021, and its period low was $22,000 during Q4 2023.
  • Moreover, its 3-year median value for Gains from Investment Securities was $2.9 million (2025), whereas its average is $3.8 million.
  • Over the last 5 years, Exponent's Gains from Investment Securities had its largest YoY gain of 7,081.82% in 2025, and its largest YoY loss of 38.70% in 2025.
  • Exponent's Gains from Investment Securities (Quarterly) stood at $32,000 in 2021, then declined by 17.46% to $12.9 million in 2022, then declined by 23.12% to $22,000 in 2023, then plummeted by 31.49% to $34,000 in 2024, then slumped by 38.70% to $4.2 million in 2025.
  • Its Gains from Investment Securities was $4.2 million in Q2 2025, compared to $1.6 million in Q1 2025 and $34,000 in Q3 2024.